Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash & Current Investments: 2022-2024

Historic Cash & Current Investments for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $820.4 million.

  • Immunocore Holdings' Cash & Current Investments fell 0.99% to $892.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 13.05%. This contributed to the annual value of $820.4 million for FY2024, which is 85.34% up from last year.
  • As of FY2024, Immunocore Holdings' Cash & Current Investments stood at $820.4 million, which was up 85.34% from $442.6 million recorded in FY2023.
  • Immunocore Holdings' Cash & Current Investments' 5-year high stood at $820.4 million during FY2024, with a 5-year trough of $402.5 million in FY2022.
  • Over the past 3 years, Immunocore Holdings' median Cash & Current Investments value was $442.6 million (recorded in 2023), while the average stood at $555.2 million.
  • Data for Immunocore Holdings' Cash & Current Investments shows a peak YoY skyrocketed of 85.34% (in 2024) over the last 5 years.
  • Immunocore Holdings' Cash & Current Investments (Yearly) stood at $402.5 million in 2022, then grew by 9.98% to $442.6 million in 2023, then spiked by 85.34% to $820.4 million in 2024.